paclitaxel has been researched along with Granulocytic Leukemia, Chronic in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (22.22) | 18.2507 |
| 2000's | 3 (33.33) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cheng, HY; Ko, FH | 1 |
| Chai, G; Chen, Q; Liu, Y; Sheng, H; Song, T; Xie, M; Yu, X; Zhang, Z | 1 |
| Meshkini, A; Yazdanparast, R | 1 |
| Acharya, S; Sahoo, SK | 1 |
| Boldogh, I; Brasier, AR; Fields, AP; Gustafson, WC; Karp, JE; Kaufmann, SH; Lu, Y; Ray, S | 1 |
| Forster, K; Hallek, M; Krause, G; Mitina, O; Obermeier, A; Simon, N; Warmuth, M | 1 |
| Ahmed, T; Darzynkiewicz, Z; Feldman, EJ; Halicka, HD; Lederman, CA; Li, X; Romero, MB; Seiter, K; Traganos, F | 1 |
| Bressolle, F; Grosse, PY; Pinguet, F | 1 |
| Larsson, BS; Mårs, U; Masquelier, M; Pålsson, M; Peterson, CO; Vitols, S | 1 |
1 trial(s) available for paclitaxel and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Evaluation of in vivo induction of apoptosis in patients with acute leukemia treated on a phase I study of paclitaxel.
Topics: Adult; Aged; Antineoplastic Agents, Phytogenic; Apoptosis; Blast Crisis; DNA Damage; Female; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Male; Middle Aged; Paclitaxel; Precursor Cell Lymphoblastic Leukemia-Lymphoma | 1995 |
8 other study(ies) available for paclitaxel and Granulocytic Leukemia, Chronic
| Article | Year |
|---|---|
Studying the enhancement of programmed cell death by combined AG1024 and paclitaxel in a model of chronic myelogenous leukemia.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; Drug Delivery Systems; Drug Therapy, Combination; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Paclitaxel; Tyrphostins; Up-Regulation | 2014 |
Mechanism of synergy of BH3 mimetics and paclitaxel in chronic myeloid leukemia cells: Mcl-1 inhibition.
Topics: Adult; Antineoplastic Agents; Biomimetic Materials; Cell Line, Tumor; Dose-Response Relationship, Drug; Drug Synergism; Female; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Middle Aged; Myeloid Cell Leukemia Sequence 1 Protein; Paclitaxel; Peptide Fragments; Proto-Oncogene Proteins | 2015 |
Involvement of oxidative stress in taxol-induced apoptosis in chronic myelogenous leukemia K562 cells.
Topics: Acetylcysteine; Antineoplastic Agents, Phytogenic; Apoptosis; Cell Line, Tumor; Drug Antagonism; Drug Screening Assays, Antitumor; Flow Cytometry; Glutathione; Humans; JNK Mitogen-Activated Protein Kinases; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Oxidative Stress; p38 Mitogen-Activated Protein Kinases; Paclitaxel; Reactive Oxygen Species; Superoxides | 2012 |
Sustained targeting of Bcr-Abl + leukemia cells by synergistic action of dual drug loaded nanoparticles and its implication for leukemia therapy.
Topics: Antineoplastic Agents; Apoptosis; Blotting, Western; Cell Cycle; Cell Line, Tumor; Cell Proliferation; Curcumin; Drug Synergism; Humans; Lactic Acid; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Potential, Mitochondrial; Nanoparticles; Paclitaxel; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Polymerase Chain Reaction; Sirolimus | 2011 |
Genomic mechanisms of p210BCR-ABL signaling: induction of heat shock protein 70 through the GATA response element confers resistance to paclitaxel-induced apoptosis.
Topics: Antineoplastic Agents, Phytogenic; Apoptosis; DNA-Binding Proteins; Drug Resistance, Neoplasm; Erythroid-Specific DNA-Binding Factors; Fusion Proteins, bcr-abl; GATA1 Transcription Factor; Genome, Human; HL-60 Cells; HSP70 Heat-Shock Proteins; Humans; K562 Cells; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Paclitaxel; Promoter Regions, Genetic; Response Elements; Transcription Factors | 2004 |
Role of p21(WAF1/CIP1) as an attenuator of both proliferative and drug-induced apoptotic signals in BCR-ABL-transformed hematopoietic cells.
Topics: Animals; Apoptosis; Benzamides; Cell Line, Transformed; Cell Proliferation; Cell Survival; Cyclin-Dependent Kinase Inhibitor p21; Fusion Proteins, bcr-abl; Hematopoietic Stem Cells; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Mice; Mice, Knockout; Paclitaxel; Piperazines; Protein Kinase Inhibitors; Protein-Tyrosine Kinases; Pyrimidines; Retroviridae; Transduction, Genetic; Tubulin Modulators | 2008 |
In vitro modulation of doxorubicin and docetaxel antitumoral activity by methyl-beta-cyclodextrin.
Topics: Antibiotics, Antineoplastic; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; beta-Cyclodextrins; Breast Neoplasms; Cisplatin; Cyclodextrins; Docetaxel; Doxorubicin; Drug Resistance, Multiple; Drug Resistance, Neoplasm; Drug Synergism; Female; Fluorouracil; Humans; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Ovarian Neoplasms; Paclitaxel; Taxoids; Tumor Cells, Cultured | 1998 |
Low density lipoprotein as a carrier of cytostatics in cancer chemotherapy: study of stability of drug-carrier complexes in blood.
Topics: Aged; Aged, 80 and over; Animals; Antineoplastic Agents; Antineoplastic Agents, Phytogenic; Doxorubicin; Drug Carriers; Female; Humans; Leukemia; Leukemia, Lymphocytic, Chronic, B-Cell; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukemia, Myeloid, Acute; Lipoproteins, LDL; Male; Mice; Mice, Inbred BALB C; Middle Aged; Paclitaxel | 2000 |